Human astrocyte cell lines reportedly contain a specific receptor for
the complement anaphylatoxin C3a based on ligand-binding studies, func
tional responses, and RNA analysis by RT-PCR. Uptake of I-125-C3a by a
strocytes was specific and reversible. Scatchard analysis indicated th
e presence of two classes of binding sites. High-affinity binding site
s were abundantly expressed (20,000-80,000 sites per cell) with an est
imated KD of 1 - 2 nM. Low-affinity binding sites with a K-D of 209 nM
were largely expressed (n greater than or equal to 4 x 10(6) sites pe
r cell) and probably did not reflect a receptor-mediated binding, but
rather an ionic interaction between C3a and the membrane. Analysis of
astrocyte mRNA by RT-PCR with three different sets of primers covering
60% of the C3a receptor (C3aR) mRNA sequence indicated that glial C3a
R was identical to the leukocytic one. Western blot analysis using a s
pecific anti-C3aR evidenced a C3aR with a molecular mass of 60,000 Da,
C3a and a superagonist peptide, E7, induced a transient increase of i
ntracellular [Ca2+] in primary culture of astrocytes, Treatment of the
ligands by carboxypeptidase B to eliminate the C-terminus Arg conside
rably decreased the [Ca2+] response. Moreover, flow cytometry experime
nts demonstrated the expression of C3aR on normal rat astrocyte membra
ne. This report brings new insight for the role of the complement syst
em in the brain inflammation response.